Clinical Trial Update: A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014) [Phase 3]

View source ↗

Summary

A Phase 3 lot-to-lot consistency study of an inactivated Varicella Zoster Virus vaccine in healthy adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Inactivated Varicella Zoster Virus Vaccine (Varicella Zoster Virus vaccine (inactivated))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 3 | Status: WITHDRAWN